Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation
Nasdaq Fintel reports that on September 18, 2023, Cantor Fitzgerald reiterated coverage of Johnson & Johnson (NYSE:JNJ) with a Overweight recommendation.
Analyst Price Forecast Suggests 16.01% Upside
As of August 31, 2023, the average one-year price target for Johnson & Johnson is 187.29. The forecasts range from a low of 168.67 to a high of $225.75. The average price target represents an increase of 16.01% from its latest reported closing price of 161.45.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Johnson & Johnson is 98,624MM, an increase of 0.87%. The projected annual non-GAAP EPS is 10.50.
- For more in-depth coverage of Johnson & Johnson, view the free, crowd-sourced company research report on Finpedia.
Johnson & Johnson Declares $1.19 Dividend
On July 20, 2023 the company declared a regular quarterly dividend of $1.19 per share ($4.76 annualized). Shareholders of record as of August 28, 2023 received the payment on September 7, 2023. Previously, the company paid $1.19 per share.